ArticleOcular oncology and pathology2024

Adjuvant Brachytherapy with Ruthenium-106 to Reduce the Risk of Recurrence of Conjunctival Melanoma after Excision.

Luise Grajewski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.